Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy.

Literature DB >> 17529876

Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy.

Takashi Ichiyama¹, Tsuneo Morishima, Madoka Kajimoto, Takeshi Matsushige, Tomoyo Matsubara, Susumu Furukawa.

Abstract

Matrix metalloproteinase-9 (MMP-9) and tissue inhibitors of metalloproteinases 1 (TIMP-1) play important roles in the function of the blood-brain barrier. Serum MMP-9 and TIMP-1 concentrations were determined in influenza virus infection with or without neurologic complications. Our results suggest that an imbalance between MMP-9 and TIMP-1 damages the blood-brain barrier and promotes febrile seizure or encephalopathy in influenza virus infection.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2007 PMID： 17529876 DOI： 10.1097/INF.0b013e31803994a0

Source DB: PubMed Journal: Pediatr Infect Dis J ISSN： 0891-3668 Impact factor: 2.129

Keyword Cloud
Cited

13 in total

1. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in non-herpetic acute limbic encephalitis.

Authors: Takashi Ichiyama; Yukitoshi Takahashi; Takeshi Matsushige; Madoka Kajimoto; Shinnosuke Fukunaga; Susumu Furukawa
Journal: J Neurol Date: 2009-08-12 Impact factor: 4.849

Review 2. Influenza-associated neurological complications.

Authors: Jenny P Tsai; Andrew J Baker
Journal: Neurocrit Care Date: 2013-02 Impact factor: 3.210

3. Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy.

Authors: Tiantian Zhang; Yogesh R Suryawanshi; Blair R Szymczyna; Karim Essani
Journal: Med Oncol Date: 2017-06-07 Impact factor: 3.738

4. Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling.

Authors: Linda M Bradley; Mia F Douglass; Dhrubamitra Chatterjee; Shizuo Akira; Bas J G Baaten
Journal: PLoS Pathog Date: 2012-04-05 Impact factor: 6.823

Review 5. Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic options.

Authors: Hiroshi Kido
Journal: Proc Jpn Acad Ser B Phys Biol Sci Date: 2015 Impact factor: 3.493

10. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.

Authors: Sajjad Muhammad; Oliver Planz; Markus Schwaninger
Journal: Cerebrovasc Dis Extra Date: 2016-08-25

Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy.

1. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in non-herpetic acute limbic encephalitis.

Review 2. Influenza-associated neurological complications.

3. Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy.

4. Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling.

Review 5. Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic options.

Review 6. Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development.

7. Neurologic Complications of Influenza B Virus Infection in Adults, Romania.

Review 8. Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.

Review 9. Neurological events related to influenza A (H1N1) pdm09.

10. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.